Volume 36, Issue 144 (October- In Press 2023)                   IJN 2023, 36(144): 0-0 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ehsani M, Seyedfatemi N, Haghani S, Abbasi A. Investigation of Anxiety, Depression and Post Traumatic Stress Symptoms in Patients Treated with Immunosuppressive Drugs during Covid-19 Pandemic. IJN 2023; 36 (144)
URL: http://ijn.iums.ac.ir/article-1-3746-en.html
1- Department of Medical Surgical Nursing, Nursing and Midwifery Care Research Center, Faculty of Nursing and Midwifery, Iran University of Medical Sciences, Tehran, Iran.
2- Nursing and Midwifery Care Reasearch Center, Faculty of Nursing and Midwifery, Iran University of Medical Sciences, Tehran, Iran.
3- Nursing and Midwifery Care Reasearch Center, Faculty of Nursing and Midwifery, Iran University of Medical Sciences, Tehran, Iran. , abbasi.hojjat42@gmail.com
Abstract:   (211 Views)
Background: Despite the significant impact of immunosuppressive drugs on controlling and treating certain diseases, their continued use can predispose patients to infectious diseases including COVID-19, leading to anxiety, depression, and post traumatic stress symptoms (PTSS). So, this study was conducted to determine the levels of anxiety, depression, and post traumatic stress symptoms (PTSS) in patients treated with immunosuppressive drug during covid-19 pandemic.
Methods: This cross-sectional descriptive study was conducted on 330 individuals with autoimmune diseases, cancer, and transplant recipients in Firoozgar and Rasoul-e-Akram educational centers from July to December 2022. The continuous sampling method was used, and the instruments used included a demographic and disease questionnaire, the Hospital Anxiety and Depression Scale (HADS), and the Impact of Event Scale-Revised (IES-R). Data analysis was done in spss v.16 using descriptive and interferal statistics.
Results: In this study, the mean age of the participants was 51.35 ±12.95.The majority of the patients in this study had normal levels of anxiety and depression (91.2% and 92.1%, respectively). In response to post traumatic stress symptoms, The mean total score of the patients was 27.71 out of 88. In addition, anxiety and depression did not have a statistically significant relation with any of the personal characteristics, diseases, and COVID-related information of the study participants, except for a significant correlation between income level and total score of post traumatic stress symptoms (P=0.043).
Conclusion: In this study, individuals receiving immunosuppressive drugs, although susceptible to COVID-19, had normal levels of anxiety and depression and obtained lower scores than the mean scores in response post traumatic stress symptoms. This finding can decrease the amount of concerns about mental health of these patients.A study using other psychological questionnaires or a qualitative study about the expriences of these patients during covid-19 pandemic is suggested in the future.
 
     
Type of Study: Research | Subject: nursing
Received: 2023/09/23 | Accepted: 2023/10/1 | Published: 2023/10/1

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2015 All Rights Reserved | Iran Journal of Nursing

Designed & Developed by : Yektaweb